During the past decade, Herz- und Gefässzentrum Bad Bevensen conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herz- und Gefässzentrum Bad Bevensen" #1 sponsor was "LivaNova" with 3 trials, followed by "MicroPort CRM" with 3 trials sponsored, "TriVascular, Inc." with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "C. R. Bard" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herz- und Gefässzentrum Bad Bevensen" #1 collaborator was "BARMER GEK Germany" with 1 trials as a collaborator, "Clinical Trial Unit, University Hospital Basel, Switzerland" with 1 trials as a collaborator, "Endologix" with 1 trials as a collaborator, "GermanVasc" with 1 trials as a collaborator and "Sorin CRM" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Herz- und Gefässzentrum Bad Bevensen" are "Atrial Fibrillation" (4 trials), "Abdominal Aortic Aneurysm" (3 trials), "Heart Failure" (3 trials), "Aortic Stenosis" (1 trials) and "Aortic Valve Replacement" (1 trials). Many other conditions were trialed in "Herz- und Gefässzentrum Bad Bevensen" in a lesser frequency.

Most popular intervention types in "Herz- und Gefässzentrum Bad Bevensen" are "Device" (15 trials), "Procedure" (3 trials), "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "ICD" (2 trials), "ACURATE TA™ Transapical Aortic Bioprosthesis" (1 trials), "AF ablation" (1 trials), "Best Medical Treatment" (1 trials) and "Bypass-Surgery" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herz- und Gefässzentrum Bad Bevensen" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Herz- und Gefässzentrum Bad Bevensen". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Herz- und Gefässzentrum Bad Bevensen, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Herz- und Gefässzentrum Bad Bevensen, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".